Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Apyx Medical (APYX) Other Operating Expenses (2016 - 2026)

Apyx Medical filings provide 11 years of Other Operating Expenses readings, the most recent being $16000.0 for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 109.82% to $16000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $9.3 million, a 5885.71% increase, with the full-year FY2025 number at $92000.0, up 157.14% from a year prior.
  • Other Operating Expenses hit $16000.0 in Q4 2025 for Apyx Medical, down from $76000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $4.7 million in Q2 2025 to a low of -$551000.0 in Q4 2022.
  • Median Other Operating Expenses over the past 5 years was -$3000.0 (2023), compared with a mean of $637111.1.
  • Biggest five-year swings in Other Operating Expenses: crashed 320.0% in 2024 and later surged 469400.0% in 2025.
  • Apyx Medical's Other Operating Expenses stood at -$185000.0 in 2021, then plummeted by 197.84% to -$551000.0 in 2022, then surged by 588.57% to $2.7 million in 2023, then tumbled by 106.05% to -$163000.0 in 2024, then skyrocketed by 109.82% to $16000.0 in 2025.
  • The last three reported values for Other Operating Expenses were $16000.0 (Q4 2025), $76000.0 (Q3 2025), and $4.7 million (Q2 2025) per Business Quant data.